policy
Guidelines for use of autogenous biologics
Autogenous biological products may provide veterinarians a unique opportunity for control of certain infectious diseases when USDA-licensed commercial…
policy
Development of emerging disease agent biologics
Development of emerging infectious disease biologics is essential for One Health. The AVMA supports the development of these products through…
JAVMA news
FDA extends call for treatment limit ideas
Food and Drug Administration authorities have extended a call for ideas on how to limit durations of some approved antimicrobial treatments in…
JAVMA news
Searching for self-replicating antimicrobials
Viruses could supplement antimicrobials, if usefulness proved
AVMA news
Gene therapy may soon help treat mitral valve disease
Phibro Animal Health and Rejuvenate Bio are developing an expected gene therapy for canine mitral valve disease.
JAVMA news
The hidden ecosystem of the gut microbiome
Millions of bacteria live in the gastrointestinal tract of animals, including cats, dogs, and humans.
JAVMA news
New listings in AVMA Animal Health Studies Database
Below are some of the new listings of veterinary clinical studies in the AVMA Animal Health Studies Database.
AVMA news
Until more science is available, FDA will end public updates on potential link between certain diets and canine dilated cardiomyopathy
The Food and Drug Administration plans to end routine updates on the investigation of case reports of nonhereditary canine dilated cardiomyopathy and…
JAVMA news
In Short
Aquarium cleaner death, anxiety in dogs, and more in the May 1 “In Short” section